213 related articles for article (PubMed ID: 23159578)
1. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
[TBL] [Abstract][Full Text] [Related]
2. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation.
Rey A; Manen D; Rizzoli R; Caverzasio J; Ferrari SL
J Biol Chem; 2006 Dec; 281(50):38181-8. PubMed ID: 17038311
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
4. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
5. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization.
Sneddon WB; Friedman PA
Endocrinology; 2007 Aug; 148(8):4073-9. PubMed ID: 17525124
[TBL] [Abstract][Full Text] [Related]
6. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
Yang Y; Wang B
Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
[TBL] [Abstract][Full Text] [Related]
7. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
Bohinc BN; Gesty-Palmer D
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling.
Syme CA; Friedman PA; Bisello A
J Biol Chem; 2005 Mar; 280(12):11281-8. PubMed ID: 15611080
[TBL] [Abstract][Full Text] [Related]
9. Arrestins in bone.
Bohinc BN; Gesty-Palmer D
Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
[TBL] [Abstract][Full Text] [Related]
10. Translating in vitro ligand bias into in vivo efficacy.
Luttrell LM; Maudsley S; Gesty-Palmer D
Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
[TBL] [Abstract][Full Text] [Related]
11. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50).
Sneddon WB; Syme CA; Bisello A; Magyar CE; Rochdi MD; Parent JL; Weinman EJ; Abou-Samra AB; Friedman PA
J Biol Chem; 2003 Oct; 278(44):43787-96. PubMed ID: 12920119
[TBL] [Abstract][Full Text] [Related]
12. Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization.
Bisello A; Manen D; Pierroz DD; Usdin TB; Rizzoli R; Ferrari SL
Mol Endocrinol; 2004 Jun; 18(6):1486-98. PubMed ID: 14988434
[TBL] [Abstract][Full Text] [Related]
13. NHERF1 regulates parathyroid hormone receptor desensitization: interference with beta-arrestin binding.
Wang B; Yang Y; Abou-Samra AB; Friedman PA
Mol Pharmacol; 2009 May; 75(5):1189-97. PubMed ID: 19188335
[TBL] [Abstract][Full Text] [Related]
14. Extracellular nucleotides enhance agonist potency at the parathyroid hormone 1 receptor.
Kim BH; Pereverzev A; Zhu S; Tong AOM; Dixon SJ; Chidiac P
Cell Signal; 2018 Jun; 46():103-112. PubMed ID: 29501726
[TBL] [Abstract][Full Text] [Related]
15. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
16. Biased agonism at the parathyroid hormone receptor: a demonstration of functional selectivity in bone metabolism.
Bohinc BN; Gesty-Palmer D
Mini Rev Med Chem; 2012 Aug; 12(9):856-65. PubMed ID: 22681253
[TBL] [Abstract][Full Text] [Related]
17. Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis.
Polyzos SA; Makras P; Efstathiadou Z; Anastasilakis AD
Expert Opin Investig Drugs; 2015 Feb; 24(2):145-57. PubMed ID: 25316089
[TBL] [Abstract][Full Text] [Related]
18. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation.
Gesty-Palmer D; Flannery P; Yuan L; Corsino L; Spurney R; Lefkowitz RJ; Luttrell LM
Sci Transl Med; 2009 Oct; 1(1):1ra1. PubMed ID: 20368153
[TBL] [Abstract][Full Text] [Related]
19. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein.
Vilardaga JP; Frank M; Krasel C; Dees C; Nissenson RA; Lohse MJ
J Biol Chem; 2001 Sep; 276(36):33435-43. PubMed ID: 11387315
[TBL] [Abstract][Full Text] [Related]
20. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
